Serum and serum exosomal hsa_circ_0069313 have the potential to discriminate NSCLC and benign lung tumor. The higher levels of serum exosomal hsa_circ_0069313 are linked to more aggressive pathological features of NSCLC.
Serum exosomal hsa_circ_0069313 has a potential to diagnose more aggressive non-small cell lung cancer.